Premium
TLR agonists: our best frenemy in cancer immunotherapy
Author(s) -
Kaczanowska Sabina,
Joseph Ann Mary,
Davila Eduardo
Publication year - 2013
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1012501
Subject(s) - cancer , immunotherapy , cancer immunotherapy , immune system , biology , clinical trial , immunology , cancer research , t cell , cancer cell , bioinformatics , genetics
Review on the ability of different TLR agonists to orchestrate antitumor immune responses, or promote tumor growth, underscoring the impact of choosing among TLR agonists when applying these therapies in the clinic.